Skip to main content
Full access
In This Issue
Published Online: 1 August 2012

In This Issue

Deep Brain Stimulation for Severe Tourette's Syndrome

Severe Tourette's syndrome that cannot be managed with medication is now being experimentally treated with deep brain stimulation. Ten of 11 patients in a series from Cannon et al. (p. 860) reported 48% reduction in motor tics and 56% reduction in phonic tics. Effects were sustained for at least 3 months, and only two patients still required pharmacotherapy. One patient discontinued the treatment because of intolerability, two patients had anxiety, and one had an electronic malfunction. The stimulating electrodes were targeted to the anteromedial globus pallidus interna. Tourette's syndrome is thought to result from a defect in the cortical-basal ganglia-thalamic-cortical neuronal circuit. Stimulation in the thalamus, pallidum, ventral caudate, and anterior internal capsule has been investigated by other centers.
Ten of 11 adults with severe Tourette's syndrome reported improvement in tic severity after DBS (Cannon et al., p. 860)

Collaborative Chronic Care to Improve Outcome for Mood and Anxiety Disorders

Woltmann et al. (p. 790) reviewed 57 trials of model collaborative chronic care programs that included elements such as patient self-management support, clinical information systems, delivery system redesign, decision support, organizational support, and community resource linkages. Across disorders and primary care and behavioral health care settings, there were significant moderate effects in depression, mental and physical quality of life, and social role function, compared to control conditions. Total health care costs did not differ from control conditions.

IQ Links Poor Childhood Nutrition and Adult Schizotypal Personality

Schizotypal personality disorder, a cluster of characteristics similar to those of schizophrenia but less severe, has been linked to malnutrition in early childhood, but this association may hinge on an intermediate relationship with IQ. In a 20-year study, Venables and Raine (CME, p. 822) found that physical stunting, anemia, and psychosocial adversity at age 3 were related to nonverbal IQ at age 11, which in turn was related to two dimensions of schizotypal personality at age 23. In an editorial (p. 777), Susser points out that success in reducing child mortality in developing countries has left millions of child survivors in poor living conditions with neurodevelopmental delays and disabilities.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: A10
PubMed: 22223008

History

Published online: 1 August 2012
Published in print: August 2012

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share